Problem statement: Answer the MCQ question.
Question: Which compound exhibits a 21.432% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)Cn3cc(CCCC[NH3+])nn3)CC2)nc(N2CCN(C(=O)Cn3cc(CC(C)O)nn3)CC2)n1.[Cl-]
b: COc1ccc(OC)c(Cc2nnc(CCC(=O)NC3CCCCC3)o2)c1
c: O=C(N/N=C/c1ccco1)C1(O)c2ccccc2-c2ccccc21
d: O=C(CSc1ccc(Br)cc1)Nc1ccccc1N1CCOCC1
e: Cn1c(SCC(=O)Nc2sccc2C#N)nnc1-c1ccccc1
Answer: b. COc1ccc(OC)c(Cc2nnc(CCC(=O)NC3CCCCC3)o2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(OC)c(Cc2nnc(CCC(=O)NC3CCCCC3)o2)c1
COc1ccc(OC)c(Cc2nnc(CCC(=O)NC3CCCCC3)o2)c1
N-cyclohexyl-3-[5-[(2,5-dimethoxyphenyl)methyl]-1,3,4-oxadiazol-2-yl]propanamide